BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Viswanadh MK, Vikas, Jha A, Reddy Adena SK, Mehata AK, Priya V, Neogi K, Poddar S, Mahto SK, Muthu MS. Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine 2020;15:2345-67. [DOI: 10.2217/nnm-2020-0167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahlawat P, Phutela K, Bal A, Singh N, Sharma S. Therapeutic potential of human serum albumin nanoparticles encapsulated actinonin in murine model of lung adenocarcinoma. Drug Deliv 2022;29:2403-13. [PMID: 35892161 DOI: 10.1080/10717544.2022.2067600] [Reference Citation Analysis]
2 Rout SK, Priya V, Vikas, Mehata AK, Muthu MS. Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology 2022;76:103785. [DOI: 10.1016/j.jddst.2022.103785] [Reference Citation Analysis]
3 Vikas, Mehata AK, Suseela MNL, Behera C, Kumari P, Mahto SK, Muthu MS. Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model. Int J Biol Macromol 2022;221:874-90. [PMID: 36089091 DOI: 10.1016/j.ijbiomac.2022.09.053] [Reference Citation Analysis]
4 Ioele G, Chieffallo M, Occhiuzzi MA, De Luca M, Garofalo A, Ragno G, Grande F. Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties. Molecules 2022;27:5436. [DOI: 10.3390/molecules27175436] [Reference Citation Analysis]
5 Singh M, Rana NK, Muthu MS, Jha A, Basu Baul TS, Koch B. Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy. Materials Today Communications 2022;31:103256. [DOI: 10.1016/j.mtcomm.2022.103256] [Reference Citation Analysis]
6 Doroudian M, Azhdari MH, Goodarzi N, O'Sullivan D, Donnelly SC. Smart Nanotherapeutics and Lung Cancer. Pharmaceutics 2021;13:1972. [PMID: 34834387 DOI: 10.3390/pharmaceutics13111972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vikas, Viswanadh MK, Mehata AK, Sharma V, Priya V, Varshney N, Mahto SK, Muthu MS. Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment. Carbohydr Polym 2021;274:118617. [PMID: 34702448 DOI: 10.1016/j.carbpol.2021.118617] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Viswanadh MK, Agrawal N, Azad S, Jha A, Poddar S, Mahto SK, Muthu MS. Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy. Int J Pharm 2021;602:120652. [PMID: 33915187 DOI: 10.1016/j.ijpharm.2021.120652] [Cited by in F6Publishing: 7] [Reference Citation Analysis]